# INVIRAGEN, INC.: Form D filings

INVIRAGEN, INC., a biotechnology company in Fort Collins, CO, filed 4 Form D notices with the SEC between 2009 and 2012. The latest, on January 24, 2012, reports $15.3 million sold of a $15.3 million offering to 24 investors.

Find out what INVIRAGEN, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20INVIRAGEN%2C%20INC.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=INVIRAGEN%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Finviragen-inc-1461681)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20INVIRAGEN%2C%20INC.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=INVIRAGEN%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Finviragen-inc-1461681)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Colorado](https://specstream.ai/data/form-d/state/colorado): 1,787 rows, by operating companies, filed since November 1, 2024, $89.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/colorado
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1613 PROSPECT PARKWAY, SUITE 100, Fort Collins, CO, 80525
- Phone: (970) 672-4918
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1461681

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 24, 2012 | Amendment | $15,307,459 | $15,307,459 | $0 | 24 | Sep 22, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1461681/000146168112000001/0001461681-12-000001-index.htm) |
| Oct 8, 2010 | Amendment | $15,307,459 | $9,852,914 | $5,454,545 | 24 | Sep 22, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1461681/000146168110000002/0001461681-10-000002-index.htm) |
| Oct 6, 2009 | New notice | $2,237,186 | $2,237,186 | $0 | 2 | Sep 22, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1461681/000146168109000003/0001461681-09-000003-index.htm) |
| Oct 6, 2009 | New notice | $15,307,459 | $4,398,369 | $10,909,090 | 24 | Sep 22, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1461681/000146168109000002/0001461681-09-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| JORGE OSORIO | Executive Officer, Promoter |  |
| HENG TONG CHOO | Director |  |
| DAN STINCHCOMB | Executive Officer, Director, Promoter |  |
| JOHN TONG NEIS | Director |  |
| FRED TONG SCHWARZER | Director |  |

## Other biotechnology companies in Colorado that filed recently

- [HealthVest Fund V LLC](https://specstream.ai/data/form-d/company/healthvest-fund-v-llc-2163605) offering · Nov 5, 2026
- [GelSana Therapeutics, Inc.](https://specstream.ai/data/form-d/company/gelsana-therapeutics-inc-2002665) $4.4 million · Oct 8, 2026
- [Renovare Therapeutics, Inc.](https://specstream.ai/data/form-d/company/renovare-therapeutics-inc-2158361) $100,000 · Oct 2, 2026
- [EnteroTrack, LLC](https://specstream.ai/data/form-d/company/enterotrack-llc-1612812) $2 million · Sep 25, 2026

[Every Form D from the week of Jan 23, 2012](https://specstream.ai/data/form-d/week/2012-01-23) · [All recent filings in Colorado](https://specstream.ai/data/form-d/state/colorado) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what INVIRAGEN, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).